Autologous Transplant versus Chimeric Antigen Receptor T-cell Therapy for Relapsed DLBCL in Partial Remission | Blood | American Society of Hematology -

Key Points. In DLBCL patients in PR after salvage, auto-HCT and CAR-T consolidation provided 2-yr PFS of 52% v 42% and OS of 69%

1442588384187207688

Aaron Goodman - “Papa Heme”

Don’t abandon autologous transplant yet for chemo sensitive relapsed DLBCL!Autologous Transplant versus Chimeric Antigen Receptor T-cell Therapy for Relapsed DLBCL in Partial Remission | Blood | American Society of Hematology https://t.co/0gZB68ke3T - view on twitter

More coverage: #Dr. Diamond

See more from Aaron Goodman - “Papa Heme”